Prions Pharmaceuticals Private Limited
About Prions Pharmaceuticals Private Limited
Data last updated:
Prions Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U52310PN2010PTC138132. Its GSTIN is 27AAFCP7930A1ZL (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shantanu Singh and Saurabh Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.33 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹46,700 (net margin 4.1%) and EBITDA of ₹2.87 Lakh (EBITDA margin 25.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 48% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Prions Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMarket Place Shop No 311, Sr. No. 58/2B On Katraj Ha, Pune, Maharashtra, India – 411060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Prions Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Prions Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Prions Pharmaceuticals Private Limited, buy the company report.
Financials of Prions Pharmaceuticals Private Limited
FY 2025 filings availablePrions Pharmaceuticals Private Limited reported revenue of ₹11.33 Lakh (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 48% over five years, including 16% growth in the latest year. EBITDA rose 445% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46,700 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.4% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prions Pharmaceuticals Private Limited, buy the company report.
Board of directors of Prions Pharmaceuticals Private Limited
Prions Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shantanu Singh Also directs: Narayan Films Private Limited | Director | 29 Mar 2023 | 3 Years 7 Months | Current |
| Saurabh Singh Also directs: Narayan Films Private Limited | Director | 29 Dec 2010 | 15 Years 10 Months | Current |
| Rashmi Ajay Labh Also directs: Narayan Films Private Limited | Director | 01 Jan 2018 | 8 Years 10 Months | Current |
Shareholding
The shareholding of Prions Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Prions Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Prions Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prions Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Prions Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCP7930A1ZL | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Prions Pharmaceuticals Private Limited, buy the company report.
Recent activity
Prions Pharmaceuticals Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Shantanu Singh was appointed as Director on 29 Mar 2023.
Frequently asked questions
Prions Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 December 2010 (16+ years old) and is registered under CIN U52310PN2010PTC138132.
Prions Pharmaceuticals has 3 current directors:
- Shantanu Singh - Director
- Saurabh Singh - Director
- Rashmi Ajay Labh - Director
The latest financial statements of Prions Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Prions Pharmaceuticals is 27AAFCP7930A1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Prions Pharmaceuticals is U52310PN2010PTC138132. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prions Pharmaceuticals was incorporated on 29 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Pune.
Shantanu Singh was appointed as Director on 29 Mar 2023. Rashmi Ajay Labh was appointed as Director on 01 Jan 2018. Shantanu Singh ceased to be Director on 01 Jan 2018. Prions Pharmaceuticals has 4 board changes on record in total.
The registered office of Prions Pharmaceuticals is at Market Place Shop No 311, Sr. No. 582B On Katraj Ha, Pune, Maharashtra, India – 411060.
Prions Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Prions Pharmaceuticals is compliant as of 01 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
